A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
Tóm tắt
Từ khóa
Tài liệu tham khảo
World Health Organization, 2012
World Health Organization, 2010
Zhao, 2010, National survey of drug-resistant tuberculosis in China, N Engl J Med, 366, 2161, 10.1056/NEJMoa1108789
Small, 2010, Tuberculosis diagnosis—time for a game change, N Engl J Med, 363, 1070, 10.1056/NEJMe1008496
Wallis, 2010, Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice, Lancet, 375, 1920, 10.1016/S0140-6736(10)60359-5
Piatek, 1998, Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis, Nat Biotechnol, 16, 359, 10.1038/nbt0498-359
El-Hajj, 2001, Detection of RIF resistance in Mycobacterium tuberculosis in a single tube with molecular beacons, J Clin Microbiol, 39, 4131, 10.1128/JCM.39.11.4131-4137.2001
Helb, 2010, Rapid detection of Mycobacterium tuberculosis and RIF resistance by use of on-demand, near-patient technology, J Clin Microbiol, 48, 229, 10.1128/JCM.01463-09
Varma-Basil, 2004, Rapid detection of RIF resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay, J Clin Microbiol, 42, 5512, 10.1128/JCM.42.12.5512-5516.2004
Blakemore, 2010, Evaluation of the analytical performance of the Xpert MTB/RIF assay, J Clin Microbiol, 48, 2495, 10.1128/JCM.00128-10
Boehme, 2010, Rapid molecular detection of tuberculosis and RIF resistance, N Engl J Med, 363, 1005, 10.1056/NEJMoa0907847
Boehme, 2011, Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study, Lancet, 377, 1495, 10.1016/S0140-6736(11)60438-8
World Health Organization, 2010
Chinese Ministry of Health, 2009
World Health Organization, 1998
Guertler, 1996, New approaches to typing and identification of bacteria using the 16S–23S rDNA spacer region, Microbiology, 142, 3, 10.1099/13500872-142-1-3
Malhotra, 2010, A mutation in Mycobacterium tuberculosis rpoB gene confers rifampin resistance in three HIV–TB cases, Tuberculosis (Edinb), 90, 152, 10.1016/j.tube.2010.01.001
Lawn, 2013, Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test, Lancet Infect Dis, 13, 449, 10.1016/S1473-3099(13)70008-2
Steingart, 2013, Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults, Cochrane Database Syst Rev, CD009593
Chang, 2012, Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis, J Infect, 64, 580, 10.1016/j.jinf.2012.02.012
Van Rie, 2012, False-positive RIF resistance on Xpert MTB/RIF: case report and clinical implications, Int J Tuberc Lung Dis, 16, 206, 10.5588/ijtld.11.0395
World Health Organization, 2011
Ashok, 1998, Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives, Emerg Infect Dis, 4, 195, 10.3201/eid0402.980207
Francis, 2008
Morris, 1995, Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis, J Infect Dis, 171, 954, 10.1093/infdis/171.4.954
Chinese Ministry of Health, 2008
Van Zyl-Smit, 2011, Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden, PLoS One, 6, 1, 10.1371/journal.pone.0028815
Marlowe, 2011, Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens, J Clin Microbiol, 49, 1621, 10.1128/JCM.02214-10